GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Longduoduo Co Ltd (OTCPK:LDDD) » Definitions » ROCE %

Longduoduo Co (Longduoduo Co) ROCE % : 1,732.53% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Longduoduo Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Longduoduo Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 1,732.53%.


Longduoduo Co ROCE % Historical Data

The historical data trend for Longduoduo Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longduoduo Co ROCE % Chart

Longduoduo Co Annual Data
Trend Jun21 Jun22 Jun23
ROCE %
- - -

Longduoduo Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 1,732.53

Longduoduo Co ROCE % Calculation

Longduoduo Co's annualized ROCE % for the fiscal year that ended in Jun. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2023 )  (A: Jun. 2022 )(A: Jun. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2023 )  (A: Jun. 2022 )(A: Jun. 2023 )
=0.029/( ( (0.611 - 1.63) + (1.483 - 2.047) )/ 2 )
=0.029/( (-1.019+-0.564)/ 2 )
=0.029/-0.7915
=-3.66 %

Longduoduo Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=2.876/( ( (3.085 - 3.173) + (2.542 - 2.122) )/ 2 )
=2.876/( ( -0.088 + 0.42 )/ 2 )
=2.876/0.166
=1,732.53 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Longduoduo Co  (OTCPK:LDDD) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Longduoduo Co ROCE % Related Terms

Thank you for viewing the detailed overview of Longduoduo Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Longduoduo Co (Longduoduo Co) Business Description

Traded in Other Exchanges
N/A
Address
Ordos Street, 419, Floor 4, Comprehensive Building, Second Light Hospital, Yuquan District, Inner Mongolia, Hohhot, CHN, 010000
Longduoduo Co Ltd through its operating subsidiaries engaged in the business of providing preventive healthcare solutions. It provides a wide range of comprehensive preventive healthcare services including disease screening, healthcare treatments, healthcare products, and other services. The company mainly focuses on the prevention of myocardial infarction, cerebral infarction, hemiplegia, and cardiovascular and cerebrovascular diseases. The company's revenues are generated from its customers in the People's Republic of China.

Longduoduo Co (Longduoduo Co) Headlines

No Headlines